Antonius Berkien
Fortune : 12 613 $ au 31/05/2026
Fortune : 12 613 $ au 31/05/2026
Antonius Berkien is currently the Chairman at Gedea Biotech AB, the Director at Nordic Pharma Licensing Group, the Senior Manager at Rijnconsult BV, the Senior Manager at KPMG Danmark A, the Chief Business Officer at Ultimovacs ASA since 2020, and the Chief Business Officer at Cantargia AB since 2024.
Previously, he worked as the Director-Global Business Development at Amgen, Inc., the Director-Competitive Intelligence at Ferring Pharmaceuticals A from 2003 to 2007, the Senior Director-Corporate Development at Takeda A from 2007 to 2013, and the Senior Manager at PricewaterhouseCoopers (Denmark) from 2001 to 2003.
He also served as the Chief Business Officer at Nuevolution AB. Mr. Berkien obtained his undergraduate degree from Saxion University of Applied Sciences.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CANTARGIA AB 0,02% | 31/12/2024 | 53 423 ( 0,02% ) | 12 613 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CANTARGIA AB | Corporate Officer/Principal | 01/10/2024 |
Rijnconsult BV
Rijnconsult BV Miscellaneous Commercial ServicesCommercial Services Specializes in management consulting and interim management services | Corporate Officer/Principal | - |
Nordic Pharma Licensing Group | Directeur/Membre du Conseil | - |
Gedea Biotech AB
Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Develops a treatment for vaginal fungal infections | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
KPMG Danmark A/S
KPMG Danmark A/S Miscellaneous Commercial ServicesCommercial Services Provides audit, tax & advisory services | Corporate Officer/Principal | 18/07/2016 |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Corporate Officer/Principal | 01/01/2007 |
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Corporate Officer/Principal | 01/01/2003 |
| AMGEN INC. | Corporate Officer/Principal | - |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Health Technology |
Rijnconsult BV
Rijnconsult BV Miscellaneous Commercial ServicesCommercial Services Specializes in management consulting and interim management services | Commercial Services |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Commercial Services |
Nuevolution AB
Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
KPMG Danmark A/S
KPMG Danmark A/S Miscellaneous Commercial ServicesCommercial Services Provides audit, tax & advisory services | Commercial Services |
Cantargia AB
Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Saxion University of Applied Sciences
Saxion University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Pharma Licensing Group | |
Gedea Biotech AB
Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Develops a treatment for vaginal fungal infections | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national